MarginsXMarginsX
Home › Markets › Health Care › PROF

Profound Medical Corp. (PROF)

PROF trades on Nasdaq in Health Care, Medical/Dental Instruments. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$7.34
-1.08% on the day
Market cap
$268.8M
Micro cap
Revenue · 2025
$16.1M
+50.7% on 2024
Net income · 2025
-$42.6M
-264.4% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:Revenues), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/1628808/000110465926024153/0001104659-26-024153-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.

Profile

FieldValue
TickerPROF on Nasdaq
SectorHealth Care
IndustryMedical/Dental Instruments
CountryCanada
IPO yearNot reported by the screener
SEC CIK0001628808
SEC industry codeSurgical & Medical Instruments & Apparatus
Incorporated inON
Canadian listingTSX: PRN

Financials · 2025

LineValue
Revenue$16.1M
Net income-$42.6M
Operating income-$41.3M
Net margin-264.4%
Operating margin-256.3%
Revenue growth+50.7%
Cash$59.7M
Total assets$77.5M
P/E (computed)Net income was not positive
P/S (computed)16.7×

Warning signs

Cash runway
12.7 months
$33.3M cash at September 30, 2026
Share count, 1 year
+21.3%
2025-11-13 to 2026-11-05 · +71.4% over 3 years
Going-concern doubt
No
10-Q filed November 5, 2026
Insider net buying, 12 months
$0
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.10-Q 2026-11-05
Cash and burn$33.3M cash; operating cash flow -$7.9M a quarter.Report 2026-09-30
Shares outstanding36,626,844 (2026-11-05); 30,193,592 a year earlier; 21,370,565 three years earlier.Cover page 2026-11-05
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months1 S-3/F-3 shelf filings; 1 424B5 takedowns, 1 at the marketLatest 2025-12-22
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorPricewaterhouseCoopers LLP, Toronto, CanadaPCAOB Form AP 2026-03-30
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $0, sold $0 on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q3 2026
2026-09-30
$9.8M-$7.7M-$5.0M$33.3M$4.5M$23.6M10-Q 2026-11-05
Q2 2026
2026-06-30
$2.5M-$9.5M-$11.3M$38.3M$4.5M$19.1M10-Q 2026-08-06
Q1 2026
2026-03-31
$5.3M-$7.1M-$8.6M$50.3M$4.5M$18.8M10-Q 2026-05-07
Q4 2025
2025-12-31
$6.0M-$8.2M-$6.6M$59.7M$4.5M$16.1M10-K 2026-03-05
Q3 2025
2025-09-30
$5.3M-$8.0M-$9.6M$24.8M$4.5M$14.3M10-Q 2026-11-05
Q2 2025
2025-06-30
$2.2M-$15.7M-$13.7M$35.2M$4.5M$11.8M10-Q 2026-08-06
Q1 2025
2025-03-31
$2.6M-$10.7M-$8.3M$46.4M$4.5M$11.9M10-Q 2026-05-07
Q4 2024
2024-12-31
$4.2M-$4.9M-$5.9M$54.9M$4.7M$10.7M10-K 2026-03-05

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document
FORM S-3
S-32026-05-12
Latest annual report10-K2026-03-05
Latest quarterly / interim10-Q2026-11-05
Latest current report
FORM 8-K
8-K2026-11-12

Source: SEC EDGAR submissions feed, 290 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week+2.9%
1 month+5.8%
3 months+11.2%
Year to date-5.7%
1 year+16.9%
From 52-week high-14.2%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Medical/Dental Instruments

TickerCompanyPriceDayMarket cap
SSIISS Innovations International Inc.$1.35-18.67%$270.7M
CLPTClearPoint Neuro Inc.$8.30-2.12%$266.1M
NPCENeuropace Inc.$7.97+5.42%$274.6M
OFIXOrthofix Medical Inc. Common Stock (DE)$6.80-5.16%$277.2M
TMCITreace Medical Concepts Inc.$4.42-16.13%$289.8M
OSUROraSure Technologies Inc.$3.60-0.55%$248.6M
INFUInfuSystems Holdings Inc.$14.79+0.48%$296.3M
PDEXPro-Dex Inc.$64.48-1.80%$206.3M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier